June 2010 Issue of MMM
Mobile Guide 2010
Stethoscope. White coat. Prescription pad. Smartphone? Mobile has grown on healthcare professionals, and as a channel for pharma companies to communicate at the point of ...
Pharma has been successful reaching physicians on mobile. What will it take for industry to engage consumers? Marc Iskowitz reports
Around 6,000 health-related apps are available for docs and consumers. James Chase looks at the shape of the market
The industry continues to figure out how to successfully integrate and optimize mobile platforms. Five experts offer some insight
Cadient Group is a leading provider of digital marketing services and technology-enabled solutions for the healthcare industry. We combine a depth of healthcare knowledge and ...
ghg (grey healthcare group) is a leading multichannel communications agency dedicated to building health brands.
Physicians Asked. We Delivered.
Inspiring change in the way clients address challenges and in the way patients cope with their conditions drives every aspect of our work. Micromass applies ...
MPR's mission is to develop integrated, multiplatform applications for healthcare professionals by leveraging the brand's 25-year history of delivering concise, up-to-date drug information on over ...
Pixels & Pills is a collaborative effort between Palio and Zemoga that leverages Palio's experience in the healthcare industry and Zemoga's digital marketing expertise to ...
innovation is our passion. technology, our world. digital, our playground.
- Guidemark Health merges with three companies to form new agency
- Five things for pharma marketers to know: Monday, October 17, 2016
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Tuesday, October 18, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- If Roche's Ocrevus is approved, the already competitive MS market will gain another player
- Top 25 neurology products, based on 2016 sales forecasts
- New science drives biopharma interest in neurological conditions
- J&J exec calls California pricing measure 'misguided'
- Five things for pharma marketers to know: Monday, October 24, 2016